As COVID-19 booster shots begin for those with compromised immune systems, researchers at the UC Davis School of Medicine continue to collect data from clinical trial participants. The goal is to help federal health authorities decide whether to expand vaccine booster shots to more people.
Although people in early 2020 hoarded toilet paper, washed their hands incessantly, and wouldn’t leave home, 11 months later the public pushed the envelope on COVID-19 safety precautions and ignored warnings as time went on, a new University of California, Davis, study suggests.
UC Davis joined one other institution, the University of Illinois at Urbana-Champaign, as the inaugural winners of the APLU Research Response to a Community in Crisis Award, announced Thursday (July 1).
A new study by UC Davis researchers confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces is infectious. The study, published June 24 in PLOS ONE, is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs.
A new study from the University of California, Davis, and the Icahn School of Medicine at Mount Sinai confirms that surgical masks effectively reduce outgoing airborne particles from talking or coughing, even after allowing for leakage around the edges of the mask. The results are published June 8 in Scientific Reports.
More than one in four COVID-19 patients develop long-haul symptoms lasting for months – even if they had mild cases, according to a handful of studies that have emerged recently.
Doctors have been estimating one-quarter to one-third of COVID-19 patients become long haulers, as many patients call themselves. Now, four studies published since February confirm that range. They show that 27% to nearly 33% of patients who had COVID-19 but did not need to be hospitalized later developed some form of long-haul COVID.
